Growth Metrics

Trinity Biotech (TRIB) Return on Invested Capital (2016 - 2022)

Trinity Biotech's Return on Invested Capital history spans 3 years, with the latest figure at 0.09% for Q4 2022.

  • On a quarterly basis, Return on Invested Capital fell 11.0% to 0.09% in Q4 2022 year-over-year; TTM through Dec 2022 was 0.09%, a 11.0% decrease, with the full-year FY2025 number at 0.0%, down 6.0% from a year prior.
  • Return on Invested Capital hit 0.09% in Q4 2022 for Trinity Biotech, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Invested Capital for TRIB hit a ceiling of 1.03% in Q3 2021 and a floor of 0.72% in Q2 2021.